AU2002361596A1 - Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process - Google Patents
Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation processInfo
- Publication number
- AU2002361596A1 AU2002361596A1 AU2002361596A AU2002361596A AU2002361596A1 AU 2002361596 A1 AU2002361596 A1 AU 2002361596A1 AU 2002361596 A AU2002361596 A AU 2002361596A AU 2002361596 A AU2002361596 A AU 2002361596A AU 2002361596 A1 AU2002361596 A1 AU 2002361596A1
- Authority
- AU
- Australia
- Prior art keywords
- fluid bed
- compositions prepared
- granulation process
- bed granulation
- intraorally disintegrating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35017901P | 2001-11-07 | 2001-11-07 | |
US60/350,179 | 2001-11-07 | ||
PCT/US2002/035664 WO2003039472A2 (en) | 2001-11-07 | 2002-11-07 | Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002361596A1 true AU2002361596A1 (en) | 2003-05-19 |
Family
ID=23375540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002361596A Abandoned AU2002361596A1 (en) | 2001-11-07 | 2002-11-07 | Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1446088A2 (en) |
JP (1) | JP2005512990A (en) |
AU (1) | AU2002361596A1 (en) |
BR (1) | BR0213973A (en) |
CA (1) | CA2466030A1 (en) |
MX (1) | MXPA04004290A (en) |
WO (1) | WO2003039472A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008016016A (en) * | 2006-06-12 | 2009-02-25 | Schering Corp | Pharmaceutical formulations and compositions of a selective antagonist of either cxcr2 or both cxcr1 and cxcr2 and methods of using the same for treating inflammatory disorders. |
CN101762646B (en) * | 2008-12-26 | 2012-09-05 | 扬子江药业集团有限公司 | Method for measuring content of lactitol |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5576014A (en) * | 1994-01-31 | 1996-11-19 | Yamanouchi Pharmaceutical Co., Ltd | Intrabuccally dissolving compressed moldings and production process thereof |
PT745382E (en) * | 1994-01-31 | 2004-04-30 | Yamanouchi Pharma Co Ltd | COMPRESSION-FORMED FORM WITH INTRA-ORAL SOLUBILITY AND PROCESS FOR ITS PRODUCTION |
JPH0867623A (en) * | 1994-08-31 | 1996-03-12 | Taisho Pharmaceut Co Ltd | Composition for taste-correcting oral preparation |
DE19617487A1 (en) * | 1996-05-02 | 1997-11-06 | Merck Patent Gmbh | Taste improvement of active pharmaceutical ingredients |
SA99191255B1 (en) * | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | celecoxib compounds |
IL144760A0 (en) * | 1999-12-08 | 2002-06-30 | Pharmacia Corp | Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
CA2362816C (en) * | 1999-12-08 | 2007-02-06 | Pharmacia Corporation | Valdecoxib compositions |
CN1638739A (en) * | 2000-08-18 | 2005-07-13 | 法玛西雅厄普约翰美国公司 | Compound for treating assuetude disturbance |
-
2002
- 2002-11-07 JP JP2003541764A patent/JP2005512990A/en active Pending
- 2002-11-07 EP EP02797073A patent/EP1446088A2/en not_active Withdrawn
- 2002-11-07 BR BR0213973-1A patent/BR0213973A/en not_active IP Right Cessation
- 2002-11-07 CA CA002466030A patent/CA2466030A1/en not_active Abandoned
- 2002-11-07 AU AU2002361596A patent/AU2002361596A1/en not_active Abandoned
- 2002-11-07 WO PCT/US2002/035664 patent/WO2003039472A2/en not_active Application Discontinuation
- 2002-11-07 MX MXPA04004290A patent/MXPA04004290A/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR0213973A (en) | 2004-08-31 |
EP1446088A2 (en) | 2004-08-18 |
WO2003039472A2 (en) | 2003-05-15 |
JP2005512990A (en) | 2005-05-12 |
CA2466030A1 (en) | 2003-05-15 |
WO2003039472A3 (en) | 2003-09-25 |
MXPA04004290A (en) | 2004-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002313236A1 (en) | Medicinal compositions | |
AU2003290734A1 (en) | Novel compounds as pharmaceutical agents | |
HK1073126A1 (en) | Photochromic polymerizable compositions | |
AU2002301386A1 (en) | Hydraulic Fluid Feeder | |
AU2002353739A1 (en) | Therapeutic compounds | |
AU2002365093A1 (en) | Therapeutic compositions | |
AU2003282722A1 (en) | Therapeutic compositions | |
AUPR600601A0 (en) | Therapeutic compositions | |
AU2002321808A1 (en) | Dental compositions | |
AU2002228243A1 (en) | Software protection by means of software modification | |
AU2002361596A1 (en) | Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process | |
AU2002338953A1 (en) | Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate | |
HUP0400080A3 (en) | Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate | |
AU2002358944A1 (en) | Novel anti-cancer therapeutic compounds | |
GB0109428D0 (en) | Therapeutic compositions | |
AU2003227733A1 (en) | Builder granules | |
GB0111043D0 (en) | Granular compositions | |
AU2002361987A1 (en) | Substituted beta-aminoalcohols used as medicaments | |
GB0123063D0 (en) | Compositions for therapy | |
AU2002316762A1 (en) | Water treatment compositions | |
AU2002314209A1 (en) | Granulation process | |
AU2002341652A1 (en) | Crustaceans as production systems for therapeutic proteins | |
AU2002334240A1 (en) | Kurkumin composition for the cure of large intestine polyps | |
AU2002230021A1 (en) | Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors | |
AU2002355394A1 (en) | Alpha-ketoamide derivatives as cathepsin k inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |